Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
- 31 January 2009
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 61 (1), 14-25
- https://doi.org/10.1016/j.addr.2008.08.007
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Prominent Expression of Xenobiotic Efflux Transporters in Mouse Extraembryonic Fetal Membranes Compared with PlacentaDrug Metabolism and Disposition, 2008
- BCRP/ABCG2 in the Placenta: Expression, Function and RegulationPharmaceutical Research, 2008
- The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance–linked ATP binding cassette drug transporter ABCG2Molecular Cancer Therapeutics, 2007
- P-Glycoprotein and Breast Cancer Resistance Protein: Two Dominant Transporters Working Together in Limiting the Brain Penetration of TopotecanClinical Cancer Research, 2007
- Anticonvulsant Hypersensitivity Syndrome: Implications for Pharmaceutical CarePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IXAmerican Journal of Physiology-Cell Physiology, 2007
- The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)British Journal of Pharmacology, 2007
- Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into MilkMolecular and Cellular Biology, 2007
- The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumoursEuropean Journal of Cancer, 2004
- Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated EffluxThe Journal of pharmacology and experimental therapeutics, 2002